NxStage Medical (NASDAQ:NXTM) : Traders are bullish on NxStage Medical (NASDAQ:NXTM) as it has outperformed the S&P 500 by a wide margin of 9.29% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 2.45%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 3.76% in the last 1 week, and is up 11.05% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The company shares have rallied 56.28% from its 1 Year high price. On Jul 8, 2016, the shares registered one year high at $23.08 and the one year low was seen on Jul 28, 2015. The 50-Day Moving Average price is $20.11 and the 200 Day Moving Average price is recorded at $17.72.
The stock has recorded a 20-day Moving Average of 10.93% and the 50-Day Moving Average is 20.04%.
NxStage Medical (NASDAQ:NXTM): stock turned positive on Friday. Though the stock opened at $21.92, the bulls momentum made the stock top out at $23.08 level for the day. The stock recorded a low of $21.9 and closed the trading day at $22.91, in the green by 4.90%. The total traded volume for the day was 945,423. The stock had closed at $21.84 in the previous days trading.
In an insider trading activity, The Securities and Exchange Commission has divulged that Turk Joseph E Jr, (President) of Nxstage Medical, Inc., had unloaded 1,500 shares at an average price of $17.89 in a transaction dated on May 12, 2016. The total value of the transaction was worth $26,835.
NxStage Medical, Inc. is a medical device company. The Company is engaged in the development, manufacturing and marketing of products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Companys products include the System One, Streamline Blood Tubing Sets and AV Fistula and Apheresis Needles. Its primary product, the System One, is a small, portable, easy-to-use hemodialysis system. It is designed to deliver the therapeutic flexibility and clinical benefits associated with traditional dialysis machines in a smaller, portable, easy-to-use form that can be used by healthcare professionals and trained lay users alike in a variety of settings, including patient homes, as well as more traditional care settings such as hospitals and dialysis centers. The Company operates in three reportable business segments: System One, In-Center and Services.